CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L306. A total of 21 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $35,000 | -22.2% | 90,700 | 0.0% | 0.00% | – |
| Q4 2015 | $45,000 | -2.2% | 90,700 | 0.0% | 0.00% | – |
| Q3 2015 | $46,000 | -37.0% | 90,700 | 0.0% | 0.00% | – |
| Q2 2015 | $73,000 | +30.4% | 90,700 | 0.0% | 0.00% | – |
| Q1 2015 | $56,000 | 0.0% | 90,700 | 0.0% | 0.00% | – |
| Q4 2014 | $56,000 | -79.7% | 90,700 | 0.0% | 0.00% | – |
| Q3 2014 | $276,000 | -0.7% | 90,700 | 0.0% | 0.00% | – |
| Q2 2014 | $278,000 | +858.6% | 90,700 | +1195.7% | 0.00% | – |
| Q4 2013 | $29,000 | -3.3% | 7,000 | 0.0% | 0.00% | – |
| Q3 2013 | $30,000 | +42.9% | 7,000 | 0.0% | 0.00% | – |
| Q2 2013 | $21,000 | – | 7,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,632,259 | $628,000 | 0.03% |
| CONDOR CAPITAL MANAGEMENT | 10,000 | $4,000 | 0.00% |
| SHUFRO ROSE & CO LLC | 17,500 | $7,000 | 0.00% |
| Krilogy Financial LLC | 600 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 934 | $0 | 0.00% |
| NORTHERN TRUST CORP | 33,166 | $13,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 86,456 | $33,000 | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,900 | $9,000 | 0.00% |
| CITIGROUP INC | 30 | $0 | 0.00% |
| GOLDMAN SACHS GROUP INC | 106,036 | $41,000 | 0.00% |